Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 5:53 pm Sale |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
EcoR1 Capital LLC | 0 0.000% |
-3,255,270 (Position Closed) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 3,125,897 6.800% |
999,762 (+47.02%) |
Filing History |
| 2024-02-14 09:43 am Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 4,579,818 9.900% |
472,873 (+11.51%) |
Filing History |
| 2024-02-09 4:31 pm Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,545,075 5.300% |
165,140 (+6.94%) |
Filing History |
| 2024-02-09 09:16 am Sale |
2024-02-08 | 13G | Janux Therapeutics, Inc. JANX |
FMR CORP | 4,671,213 10.117% |
-934,647 (-16.67%) |
Filing History |
| 2024-02-01 4:15 pm Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Bregua Corp | 3,830,257 8.300% |
81,007 (+2.16%) |
Filing History |
| 2023-11-15 6:22 pm Purchase |
2023-11-13 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 9,766,354 21.200% |
869,645 (+9.77%) |
Filing History |
| 2023-07-10 4:01 pm Purchase |
2023-06-29 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 2,126,135 5.100% |
2,126,135 (New Position) |
Filing History |
| 2023-05-30 4:45 pm Purchase |
2023-05-17 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.800% |
4,106,945 (New Position) |
Filing History |
| 2023-02-10 4:32 pm Purchase |
2022-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,379,935 5.400% |
103,323 (+4.54%) |
Filing History |
| 2023-02-09 11:40 am Sale |
2022-12-31 | 13G | Janux Therapeutics, Inc. JANX |
JANUS HENDERSON GROUP PLC JHG |
1,837,791 4.400% |
-563,102 (-23.45%) |
Filing History |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Janux Therapeutics, Inc. JANX |
FMR CORP | 5,605,860 13.455% |
614,458 (+12.31%) |
Filing History |
| 2023-01-20 5:32 pm Purchase |
2023-01-10 | 13G | Janux Therapeutics, Inc. JANX |
EcoR1 Capital LLC | 3,255,270 7.800% |
3,255,270 (New Position) |
Filing History |
| 2022-02-11 6:30 pm Purchase |
2021-12-31 | 13G | Janux Therapeutics, Inc. JANX |
JANUS HENDERSON GROUP PLC JHG |
2,400,893 5.800% |
2,400,893 (New Position) |
Filing History |
| 2022-02-11 4:01 pm Purchase |
2021-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,276,612 5.500% |
2,276,612 (New Position) |
Filing History |
| 2022-01-10 1:26 pm Purchase |
2022-01-07 | 13G | Janux Therapeutics, Inc. JANX |
FMR CORP | 4,991,402 11.995% |
4,991,402 (New Position) |
Filing History |
| 2021-12-17 5:08 pm Purchase |
2021-12-16 | 13D | Janux Therapeutics, Inc. JANX |
ORBIMED ADVISORS LLC | 2,649,464 6.400% |
2,649,464 (New Position) |
Filing History |
| 2021-06-25 06:08 am Purchase |
2021-06-15 | 13G | Janux Therapeutics, Inc. JANX |
Bregua Corp | 3,749,250 9.000% |
3,749,250 (New Position) |
Filing History |
| 2021-06-25 06:07 am Purchase |
2021-06-15 | 13D | Janux Therapeutics, Inc. JANX |
Avalon Ventures XI L.P. | 8,896,709 21.400% |
8,896,709 (New Position) |
Filing History |
| 2021-06-21 8:17 pm Purchase |
2021-06-15 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 3,042,764 7.300% |
3,042,764 (New Position) |
Filing History |